Novartis To Topple Teva As World's Largest Generics Maker
Novartis said on Monday it would buy all of privately held Hexal and the two-thirds of Eon Labs that the German company owns for roughly $7.3 billion. Novartis also expects to spend close to $1 billion for the remaining Eon shares.
The two companies will be merged into its Sandoz business,...
To view the full article, register now.